title: Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.
authors.affiliation: 1 Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden ; 2 Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden ; 3 Division of Infection and Immunity, University College London, and National Institute of Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: Markus
authors.initials: M
authors.lastname: Maeurer
authors.affiliation: 1 Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden ; 2 Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden ; 3 Division of Infection and Immunity, University College London, and National Institute of Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Rao
authors.affiliation: 1 Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden ; 2 Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden ; 3 Division of Infection and Immunity, University College London, and National Institute of Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: Alimuddin
authors.initials: A
authors.lastname: Zumla